Literature DB >> 26284556

Protective Effects of L-Carnitine Against Oxidative Injury by Hyperosmolarity in Human Corneal Epithelial Cells.

Xia Hua1, Ruzhi Deng2, Jin Li2, Wei Chi3, Zhitao Su4, Jing Lin4, Stephen C Pflugfelder4, De-Quan Li4.   

Abstract

PURPOSE: L-carnitine suppresses inflammatory responses in human corneal epithelial cells (HCECs) exposed to hyperosmotic stress. In this study, we determined if L-carnitine induces this protective effect through suppression of reactive oxygen species (ROS)-induced oxidative damage in HCECs.
METHODS: Primary HCECs were established from donor limbal explants. A hyperosmolarity dry-eye model was used in which HCECs are cultured in 450 mOsM medium with or without L-carnitine for up to 48 hours. Production of reactive oxygen species (ROS), oxidative damage markers, oxygenases and antioxidative enzymes were analyzed by 2',7'-dichlorofluorescein diacetate (DCFDA) kit, semiquantitative PCR, immunofluorescence, and/or Western blotting.
RESULTS: Reactive oxygen species production increased in HCECs upon substitution of the isotonic medium with the hypertonic medium. L-carnitine supplementation partially suppressed this response. Hyperosmolarity increased cytotoxic membrane lipid peroxidation levels; namely, malondialdehyde (MDA) and hydroxynonenal (HNE), as well as mitochondria DNA release along with an increase in 8-OHdG and aconitase-2. Interestingly, these oxidative markers were significantly decreased by coculture with L-carnitine. Hyperosmotic stress also increased the mRNA expression and/or protein production of heme oxygenase-1 (HMOX1) and cyclooxygenase-2 (COX2), but inhibited the levels of antioxidant enzymes, superoxide dismutase-1 (SOD1), glutathione peroxidase-1 (GPX1), and peroxiredoxin-4 (PRDX4). However, L-carnitine partially reversed this altered imbalance between oxygenases and antioxidant enzymes induced by hyperosmolarity.
CONCLUSIONS: Our findings demonstrate for the first time that L-carnitine protects HCECs from oxidative stress by lessening the declines in antioxidant enzymes and suppressing ROS production. Such suppression reduces membrane lipid oxidative damage markers and mitochondrial DNA damage.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26284556      PMCID: PMC4544189          DOI: 10.1167/iovs.14-16247

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  51 in total

1.  Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes.

Authors:  F Brignole; P J Pisella; M Goldschild; M De Saint Jean; A Goguel; C Baudouin
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-05       Impact factor: 4.799

Review 2.  A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress.

Authors:  Daniele Del Rio; Amanda J Stewart; Nicoletta Pellegrini
Journal:  Nutr Metab Cardiovasc Dis       Date:  2005-08       Impact factor: 4.222

Review 3.  Prevalence, burden, and pharmacoeconomics of dry eye disease.

Authors:  Stephen C Pflugfelder
Journal:  Am J Manag Care       Date:  2008-04       Impact factor: 2.229

Review 4.  Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes.

Authors:  H Esterbauer; R J Schaur; H Zollner
Journal:  Free Radic Biol Med       Date:  1991       Impact factor: 7.376

5.  Genotoxic properties of 4-hydroxyalkenals and analogous aldehydes.

Authors:  P M Eckl; A Ortner; H Esterbauer
Journal:  Mutat Res       Date:  1993-12       Impact factor: 2.433

Review 6.  The aging eye and the role of L-carnitine and its derivatives.

Authors:  Nicola Pescosolido; Barbara Imperatrice; Panagiotis Karavitis
Journal:  Drugs R D       Date:  2008

7.  Efficacy of osmoprotectants on prevention and treatment of murine dry eye.

Authors:  Wei Chen; Xin Zhang; Jinyang Li; Yu Wang; Qi Chen; Chao Hou; Qian Garrett
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-19       Impact factor: 4.799

8.  Osmoprotectants suppress the production and activity of matrix metalloproteinases induced by hyperosmolarity in primary human corneal epithelial cells.

Authors:  Ruzhi Deng; Zhitao Su; Xia Hua; Zongduan Zhang; De-Quan Li; Stephen C Pflugfelder
Journal:  Mol Vis       Date:  2014-09-12       Impact factor: 2.367

9.  Selenium compound protects corneal epithelium against oxidative stress.

Authors:  Akihiro Higuchi; Hiroyoshi Inoue; Tetsuya Kawakita; Tadashi Ogishima; Kazuo Tsubota
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

10.  Effect of reactive oxygen species generation in rabbit corneal epithelial cells on inflammatory and apoptotic signaling pathways in the presence of high osmotic pressure.

Authors:  Yihui Chen; Min Li; Bing Li; Weifang Wang; Anjuan Lin; Minjie Sheng
Journal:  PLoS One       Date:  2013-08-15       Impact factor: 3.240

View more
  21 in total

1.  Matrix regeneration agents improve wound healing in non-stressed human corneal epithelial cells.

Authors:  A Robciuc; R P J Arvola; M Jauhiainen; J M Holopainen
Journal:  Eye (Lond)       Date:  2017-12-22       Impact factor: 3.775

2.  Hyperosmolarity disrupts tight junction via TNF-α/MMP pathway in primary human corneal epithelial cells.

Authors:  Yun Zhang; Ming Yang; Shi-Xin Zhao; Li Nie; Li-Jun Shen; Wei Han
Journal:  Int J Ophthalmol       Date:  2022-05-18       Impact factor: 1.645

Review 3.  The Pathophysiology of Dry Eye Disease: What We Know and Future Directions for Research.

Authors:  Stephen C Pflugfelder; Cintia S de Paiva
Journal:  Ophthalmology       Date:  2017-11       Impact factor: 12.079

4.  IL-36α/IL-36RA/IL-38 signaling mediates inflammation and barrier disruption in human corneal epithelial cells under hyperosmotic stress.

Authors:  Jin-Miao Li; Rong Lu; Yun Zhang; Jing Lin; Xia Hua; Stephen C Pflugfelder; De-Quan Li
Journal:  Ocul Surf       Date:  2021-08-21       Impact factor: 6.268

5.  Anti-inflammatory effects of paeoniflorin from Paeonia lactiflora Pall. on human corneal epithelial cells and a mouse model of dry eye disease.

Authors:  Mincong Zhao; Li Liu; Yating Zheng; Guangrong Liu; Biao Che; Penghui Li; Huixiong Chen; Changzhi Dong; Li Lin; Zhiyun Du
Journal:  RSC Adv       Date:  2019-04-29       Impact factor: 4.036

6.  In Vitro Inhibition of NFAT5-Mediated Induction of CCL2 in Hyperosmotic Conditions by Cyclosporine and Dexamethasone on Human HeLa-Modified Conjunctiva-Derived Cells.

Authors:  Elise Warcoin; Christophe Baudouin; Carole Gard; Françoise Brignole-Baudouin
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

Review 7.  Combination of hyaluronic acid, carmellose, and osmoprotectants for the treatment of dry eye disease.

Authors:  Antonio José Mateo Orobia; Jorge Saa; Alberto Ollero Lorenzo; José María Herreras
Journal:  Clin Ophthalmol       Date:  2018-03-06

8.  Modulation of Oxidative Stress and Inflammation in the Aged Lacrimal Gland.

Authors:  Rodrigo G de Souza; Zhiyuan Yu; Humberto Hernandez; Claudia M Trujillo-Vargas; Andrea Lee; Kelsey E Mauk; Jiyang Cai; Milton R Alves; Cintia S de Paiva
Journal:  Am J Pathol       Date:  2020-11-04       Impact factor: 4.307

9.  Topical Delivery of Levocarnitine to the Cornea and Anterior Eye by Thermosensitive in-situ Gel for Dry Eye Disease.

Authors:  Baorui Ma; Linnuo Pang; Pingqing Huang; Jie Bai; Zhiqin Zhang; Huimin Wu; Mengru Cai; Jin Yang; Yuchen Xu; Xingbin Yin; Changhai Qu; Jian Ni
Journal:  Drug Des Devel Ther       Date:  2021-06-02       Impact factor: 4.162

10.  Therapeutic Efficacy of Topically Applied Antioxidant Medicinal Plant Extracts in a Mouse Model of Experimental Dry Eye.

Authors:  Won Choi; Jee Bum Lee; Lian Cui; Ying Li; Zhengri Li; Ji Suk Choi; Hyo Seok Lee; Kyung Chul Yoon
Journal:  Oxid Med Cell Longev       Date:  2016-05-26       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.